Agent for the TSH suppression and treatment of struma

• US 5,200,428 A
• Filed: 08/23/1991
• Issued: 04/06/1993
• Est. Priority Date: 08/23/1990
• Status: Expired due to Fees

• Current Assignee: Henning Berlin GmbH
• Original Assignee: Henning Berlin GmbH
• Inventors: Horst, Claus
• Primary Examiner(s): FRIEDMAN, STANLEY
• Application Number:
  US07/748,882
• Time in Patent Office: 592 Days
• Field of Search: 514/561
• US Class Current: 514/561
• CPC Class Codes: A61K 31/195 having an amino group
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: A61P 5/12 for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Abstract

The agent for TSH suppression and for treatment of struma contains a therapeutically effective dose of 3,5-diiodo-L-thyronine and conventional galenic auxiliary materials.

Claims

1. A method for suppression of TSH which comprises oral administration to a goiter patient in need thereof of a therapeutically effective dose 3,5-diido-L-thyronine.

2. The method of claim 1 wherein the dosage unit is 1-5 mg of 3,5-diiodo-L-thyronine.

3. A method of treatment of goiter wherein there is orally administered an effective amount of 3,5-diido-L-thyronine to a goiter patient in need thereof.

4. The method of claim 3 wherein the amount is 1-5 mg of 3,5-diiodo-L-thyronine.